The process of domestic production of high-end medical devices accelerates

The process of domestic production of high-end medical devices accelerates

In recent years, with the rapid development of China's medical and health industry, the localization process of high-end medical devices has accelerated significantly. Driven by policy support, technological innovation and market demand, domestic high-end medical devices are gradually breaking the monopoly of foreign capital and becoming a new highlight of the industry. The following are related topics and structured data analysis that have been hotly discussed across the Internet in the past 10 days.

1. Policy-driven: The pace of domestic substitution accelerates

The National Health Commission, the Ministry of Industry and Information Technology and other departments have recently issued intensive policies to clearly support the localization of high-end medical devices. For example, the "14th Five-Year Plan for the Development of Medical Equipment Industry" proposes that by 2025, mainstream medical equipment will basically achieve effective supply, and the domestic production rate of high-end medical equipment will be significantly improved. The following is a summary of policy trends in the past 10 days:

2. Market performance: The rise of domestic enterprises

According to public data, in the first three quarters of 2023, the market share of domestic high-end medical devices increased by 15% year-on-year, and the domestic production rate of some fields such as medical imaging and cardiovascular interventional devices has exceeded 30%. The following are the market performance of representative companies:

3. Technological breakthroughs: significant progress in key areas

The breakthroughs in core technologies of domestic high-end medical devices have become a hot topic in recent times. For example, the 5.0T ultra-high-end MRI device released by United Imaging Medical has passed the FDA certification, and Mindray Medical's ultrasound equipment has entered the supply chain of top European hospitals for the first time. The following are technical breakthrough cases in the past 10 days:

4. Challenges and prospects

Despite the acceleration of the domesticization process, high-end medical devices still face challenges such as relying on imports of core components and insufficient brand recognition. Experts pointed out that in the future, we need to strengthen cooperation between industry, academia and research, improve the coordination capabilities of the industrial chain, and further enhance competitiveness through international layout.

Overall, the localization of high-end medical devices has entered the fast lane. Driven by the triple driving of policies, technologies and markets, domestic companies are expected to occupy a more important position in global competition.